SYSTEM PROBLEMS:
We are currently experiencing technical problems with content and functionality requiring a login.
We apologize for the inconvience.
Showing session: reset
NOVEL APPROACHES TO STUDY PEDIATRIC ANTIRETROVIRAL DOSING AND SAFETY
- Sort by:
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
6 of
6
|
SESSION INTRODUCTION
Adrie Bekker
Stellenbosch University, Cape Town, South Africa
IDENTIFICATION OF AGE-APPROPRIATE DOSING STRATEGIES OF BICTEGRAVIR IN NEONATES (ABSTRACT
839)
Fazila Sadik Bunglawala
University of Liverpool, Liverpool, United Kingdom
MARAVIROC SAFETY & PHARMACOKINETICS IN HIV-EXPOSED NEONATES (ABSTRACT
842)
Julia C Rosebush
The University of Chicago, Chicago, IL, USA
ABACAVIR SAFETY AND PHARMACOKINETICS IN NORMAL AND LOW BIRTH WEIGHT INFANTS WITH HIV (ABSTRACT
843)
Tim R. Cressey
Harvard T.H. Chan School of Public Health / PHPT-IRD 174, Chiang Mai, Chiang Mai, Thailand
ADEQUATE DOLUTEGRAVIR EXPOSURE DOSED BID WITH RIFAMPICIN IN CHILDREN 6 TO <18 YEARS (ABSTRACT
847)
Hylke Waalewijn
Radboud University Medical Centre, Amsterdam, Netherlands
ABACAVIR SAFETY AND EFFICACY IN YOUNG INFANTS IN SOUTH AFRICAN OBSERVATIONAL COHORTS (ABSTRACT
845)
Renee De Waal
University of Cape Town, Cape Town, South Africa
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
6 of
6
|
